Alexandria Venture Investments

Suggest edits

Follow us

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 59

Portfolio

Portfolio Tracker

Add info

Add round

28 Oct 2021

$120,000,000

Venture capital

Middleland Capital, DNS Capital, S2G Ventures, +7

Shenandoah Growers rebrands as Soli Organic with $120m to build more soil-based indoor farms

AFN

27 Oct 2021

$215,000,000

Venture capital (Series B)

Icon Ventures, Piedmont Capital, 8VC, +3

Immunai announces a $215M Series B as its ‘immune cell atlas’ matures

TechCrunch

02 Sep 2021

$90,000,000

Venture capital (Series B)

Atlas Venture, Rock Springs Capital, OrbiMed, +7

Blood disorder biotech Disc Medicine gets $90M to bring two drugs into Phase 2

MedCity News

01 Sep 2021

$108,000,000

Venture capital (Series B)

RA Capital Management, Invus, Third Rock Ventures, +7

Asher Bio’s encouraging early data against rival cancer drug sparks $108M financing

MedCity News

14 Jul 2021

$5,000,000

Venture capital

Civilization Ventures, Alexandria Venture Investments, BoxOne Ventures, +1

Biotech co-founded by UCC graduates raises $5m funding

SiliconRepublic

16 Jun 2021

€75,000,000

Venture capital (Series A)

Redmile Group, Emerson Collective, Sofinnova Partners, +2

Round size surge gives France largest-ever Series A

Sifted

06 May 2021

$50,000,000

Venture capital (Series B)

Madrona Venture Group, Ridgeback Capital, Alexandria Venture Investments, +3

Seattle startup TwinStrand raises $50M to expand tech that identifies rare genetic mutants

GeekWire

14 Jan 2021

$23,100,000

Venture capital (Series A)

Matrix Capital Management, Alexandria Venture Investments

Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases

GeekWire

10 Sep 2020

$91,500,000

Venture capital (Series A)

Atlas Venture, MP Healthcare Venture Management, Cormorant Asset Management, +5

Korro Bio Closes $91.5M Series A Financing

FinSMEs

23 Jun 2020

$10,000,000

Venture capital (Series A)

Partnership Fund for New York City, DEFTA Partners, New York Ventures, +5

Tara Biosystems Raises $10M in Series A2 Financing

FinSMEs

11 Jun 2020

$76,000,000

Venture capital (Series B)

ARCH Venture Partners, Invus, Biotechnology Value Fund, +7

Autobahn Therapeutics Raises $76 Million To Develop Therapies For CNS Disorders

Pulse 2.0

26 May 2020

$143,000,000

Venture capital (Series B)

Andreessen Horowitz, Foresite Capital, Two Sigma Ventures, +5

insitro Raises $143M in Series B Financing

FinSMEs

01 Apr 2020

$60,000,000

Venture capital (Series A)

Atlas Venture, NEA, Partners Innovation Fund, +3

Affinia Therapeutics Raises $60M in Series A Financing

FinSMEs

25 Mar 2020

$112,000,000

Venture capital (Series C)

Greenspring Associates, Polaris Partners, Two Sigma Ventures, +7

Kallyope Raises $112M in Series C Financing

FinSMEs

25 Mar 2020

$15,500,000

Venture capital (Series A)

New York Ventures, Alexandria Venture Investments, Arkin Bio Ventures, +2

Redpin Therapeutics Secures $15.5M in Initial Closing of Series A Financing

FinSMEs

11 Mar 2020

$78,500,000

Venture capital (Series B)

U.S. Venture Partners (USVP), Alexandria Venture Investments, Nextech Invest Ltd., +5

Seattle biotech startup Silverback Therapeutics raises $78.5M

GeekWire

07 Jan 2020

$33,000,000

Venture capital (Series A)

Alta Partners, 5AM Ventures, Alexandria Venture Investments, +2

Novome Biotechnologies Secures $33M in Series A Financing

FinSMEs

07 Dec 2019

$35,000,000

Venture capital (Series A)

Alexandria Venture Investments, LLC, Surveyor Capital, +2

Jasper Therapeutics Raises $35M in Series A Financing

FinSMEs

22 Mar 2019

$7,800,000

Venture capital (Series A)

Alexandria Venture Investments

28 Feb 2019

$191,000,000

Venture capital (Series A)

Foresite Capital, ARCH Venture Partners, Third Rock Ventures, +3

Index

By TNW